Effect of frequent or extended hemodialysis on cardiovascular parameters: A meta-analysis

American Journal of Kidney Diseases

Volumn 59, Issue 5, 2012, Pages 689-699

  Susantitaphong, Paweena ^a,b,c   Koulouridis, Ioannis ^a,b   Balk, Ethan M ^b,d   Madias, Nicolaos E ^a,b   Jaber, Bertrand L ^a,b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d TUFTS UNIVERSITY   (United States)

Author keywords

conventional hemodialysis (HD); extended hemodialysis (HD); Frequent hemodialysis (HD); left ventricular mass index (LVMI); meta analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEMODIAFILTRATION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; LONG TERM CARE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859789885     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.12.020     Document Type: Article

References (80)

1. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4(suppl 1):S5-S11.
2. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study - 30 years of follow-up. Hypertension. 1989;13(suppl 5): I13-I18.
3. Weiner DE, Tighiouart H, Vlagopoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005;16(6):1803-1810. (Pubitemid 41716487)
4. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347-354. (Pubitemid 26075843)
5. Chan CT. Cardiovascular effects of frequent intensive hemodialysis. Semin Dial. 2004;17(2):99-103. (Pubitemid 38560979)
6. Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292(19):2350-2356. (Pubitemid 39491919)
7. London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001;12(12):2759-2767. (Pubitemid 33115424)
8. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463.
9. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. Acomparison study. Metabolism. 2006;55(4):515-524.
10. Lopes AA, Bragg-Gresham JL, Elder SJ, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Nutr. 2010;20(4):224-234.
11. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed. June 1, 2011.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
13. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193-206. (Pubitemid 44001277)
14. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: long-term clinical metabolic results. Kidney Int Suppl. 1988;24:S137-S140. (Pubitemid 18078157)
15. Buoncristiani U, Fagugli RM, Pinciaroli MR, Kulurianu H, Ceravolo G, Bova C. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD). Contrib Nephrol. 1996;119:152-156.
16. Traeger J, Sibai-Galland R, Delawari E, Arkouche W. Daily versus standard hemodialysis: one year experience. Artif Organs. 1998;22(7):558-563. (Pubitemid 28324028)
17. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in the Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant. 1998;13(11):2853-2860. (Pubitemid 28479534)
18. Fagugli RM, Buoncristiani U, Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs. 1998;21(7):429-431. (Pubitemid 28404956)
19. Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998;9(5):859-868. (Pubitemid 28209096)
20. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant. 1998;13(suppl 6):125-131. (Pubitemid 28356706)
21. Williams AW, O'Sullivan DA, McCarthy JT. Slow nocturnal and short daily hemodialysis: a comparison. Semin Dial. 1999;12(6):431-439.
22. Pinciaroli AR. Hormonal changes in daily hemodialysis. Seminn Dial. 1999;12(6):455-461.
23. Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int. 1999;55(6):2467-2476. (Pubitemid 29256502)
24. Cacho C, Ferrara K, Guthrie B, et al. Slow intensive home hemodialysis (SIHD): the University Hospitals of Cleveland experience. Nephrol News Issues. 2000;14(4):36-41.
25. Lindsay RM, Heidenheim AP, Leitch R, et al. Short daily versus long nocturnal hemodialysis. Daily/Nocturnal Dialysis Study Group. ASAIO J. 2001;47(5):449-455. (Pubitemid 32862304)
26. Galland R, Traeger J, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis. 2001;37(1)(suppl 2):S95-S98. (Pubitemid 32048032)
27. Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001;38(2):371-376.
28. Traeger JGR, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis: a four-year experience. Dial Transplant. 2001;30(2):76-86.
29. McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL. A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif. 2001;19(3):293-300. (Pubitemid 32217841)
30. Andre MB, Rembold SM, Pereira CM, Lugon JR. Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment. Am J Nephrol. 2002;22(5-6):473-479. (Pubitemid 36158506)
31. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant. 2002;17(8):1518-1521.
32. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61(6):2235-2239. (Pubitemid 34539341)
33. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis. 2003;42(suppl 1):13-17.
34. Koshikawa S, Akizawa T, Saito A, Kurokawa K. Clinical effect of short daily in-center hemodialysis. Nephron Clin Pract. 2003;95(1):c23-c30.
35. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003;42(5):1020-1035. (Pubitemid 37322919)
36. Haag-Weber M. Treatment options to intensify hemodialysis. Kidney Blood Press Res. 2003;26(2):90-95. (Pubitemid 36677064)
37. Reynolds JT, Homel P, Cantey L, et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif. 2004;22(3):320-328. (Pubitemid 39177739)
38. Lockridge RS Jr, Spencer M, Craft V, et al. Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia. Hemodial Int. 2004;8(1):61-69. (Pubitemid 41029674)
39. Traeger J, Galland R, Delawari E, Arkouche W, Hadden R. Six years' experience with short daily hemodialysis: do the early improvements persist in the mid and long term? Hemodial Int. 2004;8(2):151-158. (Pubitemid 41025007)
40. Williams AW, Chebrolu SB, Ing TS, et al. Early clinical, quality-of-life, and biochemical changes of "daily hemodialysis"(6 dialyses per week). Am J Kidney Dis. 2004;43(1):90-102. (Pubitemid 38049440)
41. Okada K, Abe M, Hagi C, et al. Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotension. Kidney Blood Press Res. 2005;28(2):68-76. (Pubitemid 41201985)
42. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16(9):2778-2788.
43. Weinreich T, De los Rios T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol. 2006;66(6):433-439. (Pubitemid 44896152)
44. Odar-Cederlof I, Bjellerup P, Williams A, et al. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodial Int. 2006;10(4):394-398. (Pubitemid 44489926)
45. Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J Nephrol. 2006;19(1):77-83.
46. Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung AK. A crossover study of short daily haemodialysis. Nephrol Dial Transplant. 2006;21(1):166-175. (Pubitemid 43057126)
47. He Q, Chen J, Xu Y, et al. High-risk end-stage renal disease patients converted from conventional to short daily haemodialysis. J Int Med Res. 2006;34(6):682-688. (Pubitemid 46165394)
48. Zilch O, Vos PF, Oey PL, et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens. 2007;25(6):1285-1289. (Pubitemid 46918809)
49. Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J. A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int. 2007;11(4):468-477. (Pubitemid 47534874)
50. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298(11):1291-1299. (Pubitemid 47443343)
51. Chan CT, Shen XS, Picton P, Floras J. Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients. J Hypertens. 2008;26(9):1795-1800.
52. Bergman A, Fenton SS, Richardson RM, Chan CT. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol. 2008;69(1):33-39.
53. Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G. Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapy. Int J Artif Organs. 2009;32(1):12-19.
54. Bugeja A, Dacouris N, Thomas A, et al. In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):778-783.
55. David S, Kumpers P, Eisenbach GM, Haller H, Kielstein JT. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant. 2009;24(7):2232-2240.
56. Rayment G, Chow J. The efficacy of short daily dialysis - a single-centre experience. J Ren Care. 2010;36(3):118-125.
57. Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300.
58. Ok E, Duman S, Asci G, et al. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant. 2011;26(4):1287-1296.
59. Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091.
60. National Kidney Foundation Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(suppl 1):S2-S90.
61. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010-2019. (Pubitemid 35461657)
62. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011;57(1)(suppl 1):A8, e1-e526.
63. Lindsay RM, Suri RS, Moist LM, et al. International Quotidian Dialysis Registry: annual report 2010 [published online ahead of print January 14, 2011]. Hemodial Int. doi:10.1111/j.1542-4758.2010.00521.x.
64. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003;16(2):85-94. (Pubitemid 37356820)
65. Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004;65(4):1492-1498. (Pubitemid 38406992)
66. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291-297. (Pubitemid 37088191)
67. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 2002;17(suppl 1):29-36. (Pubitemid 34157116)
68. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005;67(4):1500-1508. (Pubitemid 40463127)
69. Punal J, Lema LV, Sanhez-Guisande D, Ruano-Ravina A. Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review. Nephrol Dial Transplant. 2008;23(8):2634-2646.
70. Sesti G, Sciacqua A, Scozzafava A, et al. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens. 2007;25(2):471-477. (Pubitemid 46071947)
71. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol. 2009;4(suppl 1):S79-S91.
72. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63(5):1934-1943. (Pubitemid 36513344)
73. Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol. 2011;6(6):1326-1332.
74. Yuen DA, Kuliszewski MA, Liao C, Rudenko D, Leong-Poi H, Chan CT. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol. 2011;6(6):1345-1353.
75. Verdecchia P, Angeli F. Reversal of left ventricular hypertrophy: what have recent trials taught us? Am J Cardiovasc Drugs. 2004;4(6):369-378. (Pubitemid 39642490)
76. Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis. 2005;46(5):897-902. (Pubitemid 41505464)
77. Tsagalis G, Bakirtzi N, Manios E, et al. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece. Artif Organs. 2011;35(10):916-922.
78. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):349-357.
79. Gottdiener JS, Livengood SV, Meyer PS, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25(2):424-430.
80. Solomon SD, Appelbaum E, Manning WJ, et al. Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation. 2009;119(4):530-537.